Evidence map›Paper›PMID 39776593›Full record

ReviewSmart medicine2024

Emerging nanoprobes for the features visualization of vulnerable atherosclerotic plaques.

Xin Wang, Dan Mu, Jing Liang, Ruijing Xin, Yukun Zhang, Renyuan Liu, Mei Yao, Bing Zhang

Abstract readReview
In one paragraph

Review in Smart medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin WangDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Dan MuDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Jing LiangDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Ruijing XinDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Yukun ZhangDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Renyuan LiuDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Mei YaoDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.
Bing ZhangDepartment of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.ORCID https://orcid.org/0000-0002-3953-0290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis (AS) is a major cause of cardiovascular disease. In particular, the unpredictable rupture of vulnerable atherosclerotic plaques (VASPs) can cause serious cardiovascular events such as myocardial infarction, stroke, and even sudden death. Therefore, early evaluation of the vulnerability of atherosclerotic plaques is of great importance. However, clinical imaging techniques are only marginally useful in the presence of severe anatomical structural changes, making it difficult to evaluate plaque vulnerability at an early stage. With the development of molecular imaging and nanotechnology, specific nanoprobes constructed for the pathological features of VASPs have attracted much attention for their ability to visualize VASPs early and noninvasively at the cellular and molecular levels. Here, we outline the pathological features of VASPs, analyze the superiority and limitations of current clinical imaging techniques, introduce the rational design principles of nanoprobes, and systematically summarize the application of nanoprobes to visualize the features of VASPs at the cellular and molecular levels. In addition, we discussed the prospects and urgent challenges in this field, and we believe it will provide new ideas for the early and accurate diagnosis of cardiovascular diseases.

Indexed as

molecular imagingnanoprobespathological featuresvisualizationvulnerable atherosclerotic plaques

Identifiers

PMID39776593
PMCPMC11669784

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.